All In MedTech

Device Trial Radar · NCT02864966

A 24 Hour Occlusive Single Patch Test to Assess Acute Tolerance of Pre Lubricated Condom on a Panel of Healthy Adult Subjects

A 24 Hour Occlusive Single Patch Test to Assess, Under Dermatological Control, the Acute Cutaneous Tolerance of Pre Lubricated Kiss Condom on a Panel of Healthy Adult Subjects

Last checked: Nov 19, 2026Latest source record: Sep 9, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

33

Actual

Start

May 2016

Primary completion

May 2016

Study completion May 2016

Sponsor

Lead sponsor
Reckitt Benckiser Healthcare (UK) LimitedNot on our public-company list
Sponsor type
Industry
Collaborators
Alba Science Ltd
First posted
Aug 12, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a 24 hour patch test to determine the acute tolerance of 3 variants of condom on a panel of healthy adult subjects. The patches will be affixed to the back and remain under occlusion for 24 hours. They will then be assessed at 30 minutes and 24 hours post patch removal.

Conditions

  • Healthy

Interventions

  • CondomDevice

    This study involves testing a condom, however the device will not be used as intended. The device will be destroyed to make the test patches required for this safety study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary endpoint is the irritation of the test products according to the Cutaneous Irritancy Index value. The test products are expected to be graded as 'non-irritant' as confirmed by a dermatologist.Time frame: 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Alba Science Ltd

    Edinburgh, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.